Parexel Expands Network of Global Regulatory Experts
September 08, 2022 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel’s Jim Anthony Named to 2022 PharmaVOICE 100
September 07, 2022 10:23 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Expands Patient Access to Clinical Trials Through New Community Alliance Network
June 16, 2022 09:09 ET
|
Parexel International LLC
BOSTON, and Durham, N.C., June 16, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the launch of its Community Alliance Network, a novel...
Parexel Named 2022 Catalyst Award Winner
January 19, 2022 09:00 ET
|
Parexel International LLC
BOSTON, and DURHAM, N.C., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Recognized as “Top CRO” to Work With in WCG CenterWatch Global Site Relationship Benchmark Survey
January 11, 2022 15:30 ET
|
Parexel International LLC
BOSTON, and DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Bolsters Regulatory and Access Offering with Key Appointment
January 11, 2022 09:00 ET
|
Parexel International LLC
BOSTON, and Durham, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Releases Proprietary Biotech Market Research Report to Help Guide Companies on Navigating the Biotech Investment Landscape
January 06, 2022 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
EQT Private Equity and Goldman Sachs Asset Management Complete Acquisition of Parexel
November 15, 2021 17:03 ET
|
Parexel International LLC
EQT Private Equity and Goldman Sachs Asset Management committed to supporting Parexel’s Patients-First focus, track record of clinical excellence and dedication to qualityNewly-appointed Board of...
Parexel and Kyoto University Hospital Announce Strategic Alliance
October 20, 2021 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Strengthens Clinical Data and Digital Services Offering with Key Appointment
October 04, 2021 08:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...